Merck & Company Inc (MRK)

107.50
+0.68(+0.64%)
After Hours
107.55
+0.05(+0.05%)
- Real-time Data
  • Volume:
    3,163,681
  • Day's Range:
    106.56 - 107.50
  • 52 wk Range:
    71.50 - 107.50
Trading near 52-week High

Merck&Co has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

MRK Overview

Prev. Close
106.82
Day's Range
106.56-107.5
Revenue
58.61B
Open
106.56
52 wk Range
71.5-107.5
EPS
6.03
Volume
3,163,681
Market Cap
272.56B
Dividend (Yield)
2.76
(2.57%)
Average Volume (3m)
8,833,886
P/E Ratio
16.24
Beta
0.39
1-Year Change
35.8%
Shares Outstanding
2,535,395,974
Next Earnings Date
02 Feb 2023
What is your sentiment on Merck&Co?
or
Market is currently closed. Voting is open during market hours.

Merck & Company Inc News

Merck & Company Inc Analysis

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
67500

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Read More

Analyst Price Target

Average110.41 (+2.71% Upside)
High125
Low100
Price107.5
No. of Analysts22
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • Starting early is the best way of getting ahead to build good wealth, crypto/stocks investment without having a proper guide you will lose your money.. I lose so much money trying to trade ignorantly, I came across same nice comment about this manger Mr Jamesryan. I decided to give him a try. After two weeks of trading with him, I recovered all my losses and make extra profit of $89,000 from is trading platform. thanks for your help i really appreciate you sir... write him on IℕSTAGℝAM@. JAMESℝYAℕ, FX, AℕD, ℂℝYℙTO... write him on 🅆🄷🄰🅃🅂🄰🄿🄿 ++ 447 (458) (690) 607
    0
    • down today because stupid like cow as dow jones components
      0
      • Just started. More to go!
        0
        • it is going up
          0
          • What happen to MRK ? Time to buy ?
            0
            • it will cross 81 in coming days
              1
              • The immuno-oncology drugs are promising, but $81.65 seems a bit over-excited. It's no cure, just prolonging life a small amount in end-stage patients who were resistant to normal treatments. A pullback to $70 on the cards in the next 6months would be realistic.
                2
                • nice input
                  0
                • nice input
                  0
              • It will be going up
                0
                • Position buy will be up price
                  0